Cargando…
Regulatory Challenges in the COVID-19 Era: The Case of Tunisia
In view of the possible disruptions in the manufacturing and supply of health products following the coronavirus disease 2019 (COVID-19) pandemic, the Tunisian medicines regulatory authority was mobilized to guarantee patient safety. Teleworking has become the ultimate way of service continuity. The...
Autores principales: | Cherif, Dora, Felfel, Hajer, Drira, Chema, Aounallah, Mariam, Kadri, Meriem, Ben Rayana, Mohamed Chiheb, Razgallah Khrouf, Myriam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943945/ https://www.ncbi.nlm.nih.gov/pubmed/33143805 http://dx.doi.org/10.1017/dmp.2020.432 |
Ejemplares similares
-
Valuing health-related quality of life using a hybrid approach: Tunisian value set for the EQ-5D-3L
por: Chemli, Jaafar, et al.
Publicado: (2021) -
Economic analysis of allogeneic hematopoietic stem cell transplantation in the Bone Marrow Transplant Center of Tunisia
por: Achour, Leila, et al.
Publicado: (2023) -
Burnout among pharmacists in Tunisia during COVID-19 pandemic
por: Falfel, D., et al.
Publicado: (2022) -
Direct cost analysis of the second year post-allogeneic hematopoietic stem cell transplantation in the Bone Marrow Transplant Centre of Tunisia
por: Razgallah Khrouf, Myriam, et al.
Publicado: (2017) -
Humoral and Cellular Immunogenicity of Six Different Vaccines against SARS-CoV-2 in Adults: A Comparative Study in Tunisia (North Africa)
por: Ben Ahmed, Melika, et al.
Publicado: (2022)